Vor Bio (VOR) announced the appointment of Adi Osovsky, S.J.D. as General Counsel. Dr. Osovsky brings 17 years of corporate counsel and law firm experience in the biotechnology and pharmaceutical sectors. Dr. Osovsky joins Vor Bio from iTeos Therapeutics (ITOS), where she served as Executive Vice President, Head of Legal & Corporate Secretary.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VOR:
- Vor Biopharma Appoints Sarah Reed to Board
- Vor Biopharma Files Prospectus for $119.7M Stock Sale
- Vor Bio’s telitacicept achieved primary endpoint in Phase 3 study
- Largest borrow rate increases among liquid names
- Positive Phase 3 Results and Strong Financial Position Support Buy Rating for Vor Biopharma